Stefan D. Anker MD, PhDProfessor of (Tissue)Homeostasis in Cardiology & Metabolism, Charité Berlin, Berlin, Germany
Stefan D. Anker is Professor of (Tissue)Homeostasis in Cardiology & Metabolism (W3) at Charité Berlin (from June 2017). Dr. Anker studied medicine at Charité Berlin and completed his clinical training in Germany and the UK. He obtained his MD from Charité Medical School, Berlin, Germany (1993), and his Ph.D. (1998) at National Heart & Lung Institute of Imperial College London. He was Professor of Cardiology & Cachexia Research (W2) at Charité (2002-14), and Professor of Innovative Clinical Trials (W3) in Göttingen (2014-17).
Dr. Anker has authored more than 1,000 articles (total citations: >217,000, h-index: 179, papers with ≥300 citations: 113; source: GoogleScholar, 14. Jan., 2022) and was named Highly Cited Researcher 2015–2021. For his work Dr. Anker has won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. He was awarded a Doctor honoris causa of Medical University Wroclaw / Poland (October 2020) and of Semmelweis University Budapest/Hungary (November 2021).
Dr. Anker obtained a number of fellowships and grants, incl. from the NIH and the EU. He received grants for several IITs (3 currently running) from DZHK Germany and several industries. Dr. Anker was Vice President of the European Society of Cardiology (ESC, 2016-18), serving on the board 2012-2018. Dr. Anker serves in the board of the Heart Failure Association (HFA) of the ESC since 2006; he was HFA President (2012-14). He is founding Editor-in-Chief of ESC Heart Failure (open access, IF-2020: 4.41). Dr. Anker was member of several ESC Guideline groups (e.g. for Heart Failure in 2012 and 2016). Dr. Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders since 2008 (SCWD – see www.cachexia.org). Dr. Anker is founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and Muscle since 2010 (JCSM, 2020-IF: 12.91, see www.jcsm.info).